Because the CONCERTA tablet is nondeformable and does not appreciably change in form from the GI tract, CONCERTA should not ordinarily be administered to patients with preexisting significant gastrointestinal narrowing (pathologic or iatrogenic, such as: esophageal motility Ailments, tiny bowel inflammatory disorder, "small intestine" syndrome as a